SEARCH

SEARCH BY CITATION

References

  • Alexander SPH, Mathie A, Peters JA (2008). Guide to receptors and channels (GRAC), 3rd edition. Br J Pharmacol 153 (Suppl 2): S1S209.
  • Amobi N, Guillebaud J, Kaisary A, Lloyd-Davies RW, Turner E, Smith IC (2002). Contractile actions of imidazoline alpha-adrenoceptor agonists and effects of noncompetitive alpha1-adrenoceptor antagonists in human vas deferens. Eur J Pharmacol 462: 169177.
  • Argyle SA, McGrath JC (2000). An alpha(1A)/alpha(1L)-adrenoceptor mediates contraction of canine subcutaneous resistance arteries. J Pharmacol Exp Ther 295: 627633.
  • Baker JG, Hill SJ (2007). Multiple GPCR conformations and signaling pathways: implications for antagonist affinity estimates. Trends Pharmacol Sci 28: 374381.
  • Cavalli A, Lattion AL, Hummler E, Nenniger M, Pedrazzini T, Aubert JF et al. (1997). Decreased blood pressure response in mice deficient of the α1b-adrenergic receptor. Proc Natl Acad Sci USA 94: 1158911594.
  • Daniels DV, Gever JR, Jasper JR, Kava MS, Lesnick JD, Meloy TD et al. (1999). Human cloned alpha1A-adrenoceptor isoforms display alpha1L-adrenoceptor pharmacology in functional studies. Eur J Pharmacol 370: 337343.
  • Flavahan NA, Vanhoutte PM (1986). Alpha-1 and alpha-2 adrenoceptor: response coupling in canine saphenous and femoral veins. Trends Pharmacol Sci 7: 347349.
  • Ford AP, Arredondo NF, Blue Jr DR, Bonhaus DW, Jasper J, Kava MS et al. (1996). RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classification. Mol Pharmacol 49: 209215.
  • Ford AP, Daniels DV, Chang DJ, Gever JR, Jasper JR, Lesnick JD et al. (1997). Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification. Br J Pharmacol 121: 11271135.
  • Furchgott RF (1972). The classification on adrenoceptors (adrenergic receptors): an evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (eds). Handbuch der Experimentellen Pharmacology, vol. 3, Springer: New York, pp 283335.
  • Gray KT, Ventura S (2006). Alpha 1L-adrenoceptors mediate contractions of the isolated mouse prostate. Eur J Pharmacol 540: 155161.
  • Hieble JP, Bylund DB, Clarke DE, Eikenburg DC, Langer SZ, Lefkowitz RJ et al. (1995). International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. Pharmacol Rev 47: 267270.
  • Hiraizumi-Hiraoka Y, Tanaka T, Yamamoto H, Suzuki F, Muramatsu I (2004). Identification of alpha-1L adrenoceptor in rabbit ear artery. J Pharmacol Exp Ther 310: 9951002.
  • Hiraoka Y, Ohmura T, Oshita M, Watanabe Y, Morikawa K, Nagata O et al. (1999). Binding and functional characterization of alpha 1-adrenoceptor subtypes in the rat prostate. Eur J Pharmacol 366: 119126.
  • Joseph SS, Lynham JA, Molenaar P, Grace AA, Colledge WH, Kaumann AJ (2003). Intrinsic sympathomimetic activity of (−)-pindolol mediated through a (−)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors. Naunyn Schmiedebergs Arch Pharmacol 368: 496503.
  • Kaumann AJ, Engelhardt S, Hein L, Molenaar P, Lohse M (2001). Abolition of (−)-CGP 12177-evoked cardiostimulation in double beta1/beta2-adrenoceptor knockout mice. Obligatory role of beta1-adrenoceptors for putative beta4-adrenoceptor pharmacology. Naunyn Schmiedebergs Arch Pharmacol 363: 8793.
  • Kaumann AJ, Molenaar P (1996). Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat. Br J Pharmacol 118: 20852098.
  • Kenakin T, Morgan P, Lutz M (1995). On the importance of the ‘antagonist assumption’ to how receptors express themselves. Biochem Pharmacol 50: 1726.
  • Konkar AA, Zhai Y, Granneman JG (2000). Beta1-adrenergic receptors mediate beta3-adrenergic-independent effects of CGP 12177 in brown adipose tissue. Mol Pharmacol 57: 252258.
  • Lomasney JW, Cotecchia S, Lefkowitz RJ, Caron MG (1991). Molecular biology of alpha-adrenergic receptors: implications for receptor classification and for structure–function relationships. Biochim Biophys Acta 1095: 127139.
  • McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N et al. (1998). RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393: 333339.
  • Michelotti GA, Price DT, Schwinn DA (2000). Alpha-1 adrenergic receptor regulation: basic science and clinical implications. Pharmacol Ther 88: 281309.
  • Morishima S, Suzuki F, Yoshiki H, Anisuzzaman AS, Sathi ZS, Tanaka T et al. (2008). Identification of the alpha(1L)-adrenoceptor in rat cerebral cortex and possible relationship between alpha(1L)- and alpha(1A)-adrenoceptors. Br J Pharmacol 153: 14851494.
  • Morishima S, Tanaka T, Yamamoto H, Suzuki F, Akino H, Yokoyama O et al. (2007a). Identification of alpha-1L and alpha-1A adrenoceptors in human prostate by tissue segment binding. J Urol 177: 377381.
  • Morishima S, Tanaka T, Yamamoto H, Suzuki F, Akino H, Yokoyama O et al. (2007b). α1-Adrenoceptor in lower urinary tract. J Pharmacol Sci 103 (Suppl I): 40P.
  • Morrow AL, Creese I (1986). Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4101 and [3H]prazosin binding. Mol Pharmacol 29: 321330.
  • Muramatsu I, Murata S, Isaka M, Piao HL, Zhu J, Suzuki F et al. (1998). Alpha1-adrenoceptor subtypes and two receptor systems in vascular tissues. Life Sci 62: 14611465.
  • Muramatsu I, Ohmura T, Kigoshi S (1995). Pharmacological profiles of a novel alpha 1-adrenoceptor agonist, PNO-49B, at alpha 1-adrenoceptor subtypes. Naunyn Schmiedebergs Arch Pharmacol 351: 29.
  • Muramatsu I, Ohmura T, Kigoshi S, Hashimoto S, Oshita M (1990). Pharmacological subclassification of alpha 1-adrenoceptors in vascular smooth muscle. Br J Pharmacol 99: 197201.
  • Muramatsu I, Tanaka T, Suzuki F, Li Z, Hiraizumi-Hiraoka Y, Anisuzzaman AS et al. (2005). Quantifying receptor properties: the tissue segment binding method—a powerful tool for the pharmacome analysis of native receptors. J Pharmacol Sci 98: 331339.
  • Murata S, Taniguchi T, Muramatsu I (1999). Pharmacological analysis of the novel, selective alpha1-adrenoceptor antagonist, KMD-3213, and its suitability as a tritiated radioligand. Br J Pharmacol 127: 1926.
  • Nakamura S, Taniguchi T, Suzuki F, Akagi Y, Muramatsu I (1999). Evaluation of α1-adrenoceptors in the rabbit iris: pharmacological characterization and expression of mRNA. Br J Pharmacol 127: 13671374.
  • Nelson CP, Challiss RA (2007). ‘Phenotypic’ pharmacology: the influence of cellular environment on G protein-coupled receptor antagonist and inverse agonist pharmacology. Biochem Pharmacol 73: 737751.
  • Ohmura T, Oshita M, Kigoshi S, Muramatsu I (1992). Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies. Br J Pharmacol 107: 697704.
  • Oshita M, Kigoshi S, Muramatsu I (1993). Pharmacological characterization of two distinct alpha 1-adrenoceptor subtypes in rabbit thoracic aorta. Br J Pharmacol 108: 10711076.
  • Piao H, Taniguchi T, Nakamura S, Zhu J, Suzuki F, Mikami D et al. (2000). Cloning of rabbit alpha(1b)-adrenoceptor and pharmacological comparison of alpha(1a)-, alpha(1b)- and alpha(1d)-adrenoceptors in rabbit. Eur J Pharmacol 396: 917.
  • Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W et al. (2002). International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54: 233246.
  • Ramsay D, Carr IC, Pediani J, Lopez-Gimenez JF, Thurlow R, Fidock M et al. (2004). High-affinity interactions between human alpha1A-adrenoceptor C-terminal splice variants produce homo- and heterodimers but do not generate the alpha1L-adrenoceptor. Mol Pharmacol 66: 228239.
  • Rokosh DG, Simpson PC (2002). Knockout of the alpha 1A/C-adrenergic receptor subtype: the alpha 1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure. Proc Natl Acad Sci USA 99: 94749479.
  • Rokosh DG, Stewart AF, Chang KC, Bailey BA, Karliner JS, Camacho SA et al. (1996). α1-Adrenergic receptor subtype mRNAs are differentially regulated by α1-adrenergic and other hypertrophic stimuli in cardiac myocytes in culture and in vivo: repression of α1B and α1D but induction of α1C. J Biol Chem 271: 58395843.
  • Sadalge A, Coughlin L, Fu H, Wang B, Valladares O, Valentino R et al. (2003). Alpha 1d Adrenoceptor signaling is required for stimulus induced locomotor activity. Mol Psychiatry 8: 664672.
  • Sarsero D, Molenaar P, Kaumann AJ (1998). Validity of (−)-[3H]-CGP 12177A as a radioligand for the ‘putative beta4-adrenoceptor’ in rat atrium. Br J Pharmacol 123: 371380.
  • Simpson PC (2006). Lessons from knockouts: the alpha-1-Ars. In: Perez DM (ed). Adrenergic Receptors in the 21st Century. Humana Press: Totowa, NJ. pp 207240.
  • Stam WB, Van der Graaf PH, Saxena PR (1999). Analysis of alpha 1L-adrenoceptor pharmacology in rat small mesenteric artery. Br J Pharmacol 127: 661670.
  • Su TH, Morishima S, Suzuki F, Yoshiki H, Anisuzzaman ASM, Tanaka T et al. (2008). Native profiles of α1A-adrenoceptor phenotypes in rabbit prostate. Br J Pharmacol [e-pub ahead of print: advance online 25 July 2008; doi:10.1038/bjp.2008.318).
  • Suzuki F, Taniguchi T, Nakamura S, Akagi Y, Kubota C, Satoh M et al. (2002). Distribution of alpha-1 adrenoceptor subtypes in RNA and protein in rabbit eyes. Br J Pharmacol 135: 600608.
  • Tanoue A, Nasa Y, Koshimizu T, Shinoura H, Oshikawa S, Kawai T et al. (2002). The α1D-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction. J Clin Invest 109: 765775.
  • Van der Graaf PH, Deplanne V, Duquenne C, Angel I (1997). Analysis of alpha1-adrenoceptors in rabbit lower urinary tract and mesenteric artery. Eur J Pharmacol 327: 2532.
  • Zhong H, Minneman KP (1999). Alpha1-adrenoceptor subtypes. Eur J Pharmacol 375: 261276.